AntiThrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): study design and methodology for an international, adaptive Bayesian randomized controlled trial

B L Houston, P R Lawler, EC Goligher, M E Farkouh, Charlotte A Bradbury, M Carrier, V Dzavik, D Fergusson, R A Fowler, J P Galanaud, P Gross, E G McDonald, M Husain, S R Khan, A Kumar, J. Marshall, S Murthy, A Slutsky, A F Turgeon, S BerryR S Rosenson, G Escobedo, J C Nicolau, R Zarychanski*

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)

Fingerprint Dive into the research topics of 'AntiThrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): study design and methodology for an international, adaptive Bayesian randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences